Related by context. All words. (Click for frequent words.) 73 NGX# 73 oral prodrug 72 tezampanel 71 ONCONASE R 71 oral picoplatin 71 Archexin 70 CCR9 antagonist 69 alvespimycin 69 Panzem R NCD 69 torezolid phosphate 69 forodesine 68 TOCOSOL Paclitaxel 68 Zenvia ™ 68 PDE4 inhibitor 68 OvaRex R 68 Surfaxin LS 68 HGS ETR2 68 adipiplon 68 ARIKACE ™ 68 cannabinor 68 incyclinide 68 Anavex #-# 68 Phase IIb clinical trials 68 ulimorelin 68 CR# vcMMAE 68 HGS# 68 Squalamine 68 PRT# 68 TELINTRA 68 generation purine nucleoside 68 Azedra TM 68 Phase Ib study 67 NP2 Enkephalin 67 R#/MEM # 67 Phase 1a clinical 67 OMNARIS HFA 67 aplindore 67 oral methylnaltrexone 67 Zavesca r 67 AQ4N 67 Exelixis compounds 67 Allovectin 7 R 67 receptor tyrosine kinase inhibitor 67 SNT MC# 67 tanespimycin 67 INCB# [001] 67 class mGluR5 inhibitor 67 acyclovir Lauriad R 67 Chemophase 67 AeroLEF TM 67 Pimavanserin 67 faropenem 67 tiapamil 67 phase IIa clinical 67 vosaroxin 67 TOCOSOL Camptothecin 67 ospemifene 67 YONDELIS 67 IMC #B 67 Personalized Immunotherapy 66 novel VDA molecule 66 phase IIb clinical 66 Altastaph 66 ruxolitinib 66 confirmatory Phase III 66 XP# XP# 66 JAK2 inhibitor 66 Bicifadine 66 XL# anticancer compounds 66 CMV vaccine 66 Phase #b/#a clinical 66 CB2 selective receptor agonist 66 HuLuc# 66 targeted radiotherapeutic 66 AZILECT R 66 HepeX B 66 metastatic sarcomas 66 LibiGel ® 66 orally administered inhibitor 66 Zemiva TM 66 liposomal formulation 66 Trofex 66 EP #R 66 ganetespib 66 CEQ# 66 including eniluracil ADH 66 Icatibant 66 Panzem R 66 GLP toxicology studies 66 AzaSite Plus 66 Preclinical studies suggest 66 DCCR 66 CG# [003] 66 GAMMAGARD 66 GALNS 66 ZOLINZA 66 CYT# potent vascular disrupting 66 intranasal formulation 66 vidofludimus 66 Ophena TM 66 Genz # 66 Solazed TM 65 epigenetic therapies 65 TBC# 65 LEP ETU 65 TKM ApoB 65 Ketotransdel 65 Prednisporin TM 65 DPX Survivac 65 JAK inhibitor 65 ASONEP 65 deforolimus 65 MAGE A3 ASCI 65 ularitide 65 AAG geldanamycin analog 65 AZILECT ® 65 Arikace 65 novel emulsion formulation 65 IMA# 65 PLK1 SNALP 65 Insegia 65 GMX# 65 Phase IIb trials 65 LE DT 65 LUVENIQ 65 Lixivaptan 65 SILENOR 65 ATL# [002] 65 XmAb# 65 phase IIa 65 Phase IIB 65 IAP inhibitor 65 Phase IIIb clinical 65 GRN# 65 Capesaris 65 Phase IIa trials 65 intranasal delivery 65 Tyrima 65 BEMA Buprenorphine 65 rALLy clinical trial 65 ALN PCS 65 ISTODAX 65 ganaxolone 65 visilizumab 65 cystinosis patients 65 ESBA# 65 oral salmon calcitonin 65 registrational 65 docetaxel Taxotere ® 65 cMET 65 EndoTAG TM -1 65 HuMax EGFr 65 Spiegelmer ® 65 investigational monoclonal antibody 65 velafermin 65 HCV protease inhibitors 65 PNP inhibitor 65 successfully commercialize Iluvien 65 oral ridaforolimus 65 THR beta agonist 65 Pruvel 65 CINQUIL 65 BAY #-# 65 Phase Ib 65 R#/MEM 65 BEMA TM Fentanyl 65 PXD# 65 metaglidasen 65 KL4 surfactant 65 Memryte 65 Factor VIIa 65 OncoVEX GM CSF 65 Solazed 65 inhaled AAT 64 oral taxane 64 Nektar proprietary 64 Octreolin 64 bortezomib Velcade 64 HGS ETR1 64 Excellagen 64 Romidepsin 64 lomitapide 64 PEG SN# 64 Ceflatonin 64 axitinib 64 Golimumab 64 BENLYSTA ® 64 Bezielle 64 Fx #A 64 ICA # 64 trastuzumab DM1 T DM1 64 eniluracil 64 pharmacokinetic PK study 64 urocortin 2 64 Exherin TM 64 SYN# 64 MDS AML 64 therapeutic monoclonal antibody 64 EVIZON TM 64 ponatinib 64 molecular imaging radiopharmaceutical 64 volociximab 64 selective androgen receptor modulator 64 PEG PAL 64 subcutaneous Herceptin 64 zileuton injection 64 dexanabinol 64 Bioral Amphotericin B 64 atacicept 64 phase IIb III 64 Onalta ™ 64 lintuzumab SGN 64 talactoferrin 64 Stedivaze 64 Aurora kinase inhibitor 64 macitentan 64 Marqibo TM 64 opioid induced bowel dysfunction 64 TMC# [002] 64 NTDDS 64 INT# [002] 64 alvimopan 64 HCD# [002] 64 Pyridorin 64 PHX# 64 leading oral taxane 64 FOLOTYN ® 64 Fibrillex TM 64 Safinamide 64 XL# XL# XL# XL# 64 Angiocept 64 MAXY G# 64 paclitaxel poliglumex 64 Synavive 64 KRN# 64 Alocrest 64 dextofisopam 64 Azedra 64 NPSP# 64 severe hypercholesterolemia 64 sargramostim 64 LEVADEX ™ 64 rEV# 64 CDP# 64 HuMax CD4 64 faropenem medoxomil 64 non nucleoside 64 KIACTA ™ 64 novel oral anticoagulant 64 DXL# 64 PGL# 64 Phase #b/#a 64 Plicera 64 enzastaurin 64 Perforomist ™ Inhalation Solution 64 EGS# 64 ALGRX 64 overactive bladder AA# 64 riociguat 64 pharmacodynamic PD 64 otelixizumab 64 MAXY VII 64 GVAX ® 64 omega interferon 64 PRX # 64 isoform selective 64 CA9 SCAN 64 docetaxel Taxotere R 64 Urocidin 64 anti angiogenic agents 64 CTAP# Capsules 64 Clolar ® 64 PrevOnco ™ 64 vemurafenib 64 Civacir 64 MyVax personalized immunotherapy 64 Generx ™ 64 vorinostat 64 custirsen 64 PrevOnco 64 Alvesco R 64 CRMD# 64 HGS ETR1 mapatumumab 64 Zingo TM 64 Traficet EN 64 Aggrastat ® tirofiban hydrochloride 63 Ramoplanin 63 mGluR5 NAM 63 RIGScan CR 63 CCX# 63 novel anticancer 63 Aganocide 63 Zybrestat 63 phase IIb 63 StemEx 63 XL# XL# 63 Optiquel ™ 63 blood clot dissolver 63 BRIM2 63 Virulizin ® 63 EFAPROXYN 63 Proellex TM 63 BrachySil TM 63 elotuzumab 63 HDL Selective Delipidation 63 hypoxia activated prodrug 63 Dyloject TM 63 Firazyr 63 Tectin TM 63 diabetic neuropathic pain 63 Dalbavancin 63 Excellarate TM 63 thetreatment 63 Oral NKTR 63 Phase 2a trial 63 Lauriad 63 BNC# 63 BLA filing 63 JP-#/fipamezole 63 IND enabling 63 afamelanotide 63 Sym# 63 Xanafide 63 rALLy 63 PREOS 63 dirucotide MBP# 63 rxRNA 63 reslizumab 63 EVIZON TM squalamine lactate 63 candidate CRLX# 63 investigational therapies 63 Hsp# inhibition 63 Cloretazine ® 63 subcutaneous formulation 63 Zelrix 63 GnRH antagonist 63 MOZOBIL 63 forodesine hydrochloride 63 Q#IR 63 aldehyde dehydrogenase ALDH2 deficiency 63 triphendiol 63 systemically administered 63 opioid induced constipation 63 Proxinium TM 63 phase Ib 63 squalamine 63 trial evaluating PRX# 63 TYZEKA 63 BAL# [002] 63 ostarine 63 DAVANAT 63 dextromethorphan quinidine 63 Zysolin TM 63 Zemiva ™ 63 rhIGF-I/rhIGFBP-3 63 Pafuramidine 63 phase IIb trial 63 Phase 1b trial 63 preclinically 63 OncoGel 63 Iluvien TM 63 Phase Ib clinical 63 hoFH 63 TRIOLEX HE# APOPTONE HE# 63 inhaled liposomal ciprofloxacin 63 Nanobody ® 63 YONDELIS R 63 unoprostone isopropyl 63 induced macular edema 63 Panzem NCD 63 celgosivir 63 TPI ASM8 63 RhuDex ® 63 CORT # 63 ALTROPANE 63 SAR# [004] 63 oral talactoferrin 63 NOX E# 63 Alzhemed TM 63 Phase 2b clinical trials 63 favorable pharmacokinetic profile 63 MCSP respectively 63 IV APAP 63 Aflibercept 63 eprotirome 63 evaluating tivozanib 63 PRTX 63 OvaRex ® MAb 63 CoFactor 63 REMOXY ® 63 Phenoptin 63 defensin mimetic antibiotic 63 Cutanea 63 immune modulating 63 Allovectin 7 63 MOVIPREP R 63 vascular disrupting agents 63 SinuNase TM 63 Initiates Phase II 63 Elagolix 63 delivers fluocinolone acetonide FA 63 lumiliximab 63 TransVax ™ 63 MEK Inhibitor 63 Omacetaxine 63 Solulin 63 CYT# QbG# 63 orally bioavailable 63 elagolix 63 Prosaptide 63 IAP inhibitors 63 beta 1a 63 CRx 63 LEVADEX TM 63 mertansine 63 Rasagiline 63 SinuNase ™ 63 treprostinil 63 hepatitis C protease inhibitor 63 L BLP# 63 obatoclax 63 antiangiogenic agents 63 MEK inhibitors 63 MyVax ® 63 MKC# MT 63 huC# DM4 63 RGB # 63 Allovectin 7 ® 63 Aurexis 63 acyclovir Lauriad ® 63 APEX PD 63 DDP# 63 Trofex TM 63 ATL# [001] 63 peripherally acting 63 Quinamed 63 Asentar 63 MAP# 63 Aclidinium 63 Evoltra ® 63 JAK inhibitors 63 Simulect 63 fosbretabulin 63 endothelin antagonist 63 uric acid lowering 63 UPLYSO 63 liprotamase 63 synthetic retinoid 63 Aerosurf 63 sapacitabine CYC# 63 PDX pralatrexate 63 Deforolimus 63 orally inhaled migraine 63 humanised monoclonal antibody 63 Pivotal Phase III 63 XmAb ® 62 LymphoStat B TM 62 PEGylated interferon 62 Forodesine HCl 62 AEG# 62 ALN TTR# 62 initiate Phase 1b 62 Onconase 62 Phase IIb III 62 Microplasmin 62 entinostat 62 Rebif ® 62 TOCOSOL 62 Zenvia TM 62 iroxanadine 62 kidney urologic 62 Synavive ™ 62 FM VP4 62 SPRYCEL ® 62 Phase #/#a trial 62 CD# CEA 62 sorafenib tablets 62 Phase 2a clinical trials 62 SonoLysis 62 treat chronic sinusitis 62 SILENOR TM 62 Triapine 62 DCVax ® Brain 62 ixabepilone 62 Relivar 62 eltrombopag 62 Tesetaxel 62 lesinurad 62 DIFICID ™ 62 canakinumab 62 histamine dihydrochloride 62 radiation sensitizer 62 Anthim 62 acetonide FA 62 cangrelor 62 clevidipine 62 Prodarsan ® 62 HuMax CD# 62 Tß4 62 octreotide implant 62 Behcet uveitis 62 CIMZIA TM 62 investigational humanized monoclonal antibody 62 Tasimelteon 62 Phase Ib clinical trials 62 MEND CABG II 62 Orally administered 62 LBH# 62 Mipomersen 62 rALLy trial 62 Dual Opioid 62 SAR# [002] 62 oral PTH 62 MNTX 62 MGd 62 candidate TNFerade biologic 62 Anidulafungin 62 catheter occlusion 62 Tarvacin Anti Cancer 62 OHR/AVR# 62 MyVax R 62 Marqibo 62 PDE# inhibitors 62 immunomodulatory therapy 62 ritonavir boosted danoprevir 62 sitaxsentan 62 Xyfid TM 62 sorafenib Nexavar 62 small molecule tyrosine 62 Phase #b/#a trial 62 MKC# MKC# PP 62 lintuzumab 62 diarrhea predominant irritable 62 antibody MAb 62 treating neuropathic pain 62 lucinactant 62 optimal dosing regimens 62 castrate resistant prostate cancer 62 Glybera 62 Chimigen TM 62 virus HCV protease inhibitor 62 Cloretazine R VNP#M 62 selective modulator 62 Phase III confirmatory 62 USL# 62 GATTEX ™ 62 Pegloticase 62 Targretin capsules 62 FOLFOX6 chemotherapy regimen 62 Androxal ® 62 Dual Opioid TM 62 ocular formulation 62 Azedra ™ 62 PI3K/Akt pathway inhibitor 62 ORENCIA R 62 IIa trial 62 bicifadine 62 ENMD # 62 Multiple Ascending Dose 62 Cannabinor 62 systemic immunosuppressive drugs 62 tolevamer 62 ELND# 62 tesetaxel 62 MGCD# [001] 62 cilengitide 62 Proquin XR 62 Anturol TM 62 PREOS R 62 Phase 2b Clinical Trial 62 budesonide foam 62 CCR5 mAb 62 Allovectin 7 r 62 GED aPC 62 Panzem 62 Cx# [002] 62 refractory chronic lymphocytic 62 Troxatyl 62 refractory Hodgkin lymphoma 62 personalized immunotherapy 62 Annamycin 62 glucokinase activator 62 pradefovir 62 NV1FGF 62 IL# PE#QQR 62 iii GTx 62 IMC A# 62 CCR5 antagonist 62 weekly subcutaneous injections 62 Aplidin 62 Vilazodone 62 Menerba 62 dalbavancin 62 intradermal injection 62 EpiCept NP 1 62 TKM PLK1 62 DCVax R 62 Firazyr ® 62 Clonicel 62 histone deacetylase HDAC inhibitor 62 MAA submission 62 CINOD 62 lymphoid malignancies 62 belinostat 62 imexon 62 Vaxfectin TM 62 Cytolin R 62 ELACYT 62 Daclizumab 62 NPC 1C 62 regorafenib 62 potent antiproliferative 62 Cetrorelix 62 GAP #B# 62 Entereg R 62 Advagraf 62 SUTENT ® 62 LymphoStat B belimumab 62 MGN# 62 CA4P 62 p# inhibitor 62 P#X# antagonist 62 VEGF inhibitors 62 PresbyLens ® 62 KNS # 62 systemic RNAi therapeutic 62 Alexza Staccato 62 omiganan 62 midstage clinical 62 Myocet 62 Curaxin 62 mGluR2 NAM 62 anti thrombotic 62 PSMA ADC 62 IRX 2 62 PEGPH# 62 CBLC# 62 immunotherapeutic vaccine 62 Nanobody 62 ALN TTR 62 Viprinex 62 IMiDs 62 lenalidomide dexamethasone 62 NEUGENE 62 Initiates Phase III 62 methylnaltrexone 62 nephropathic cystinosis 62 Glypromate 62 neratinib 62 Neo Kidney Augment 62 Cellegesic 62 Octreotide 62 HuMax TAC 62 GLP1 agonist 62 CIMZIA R 62 Luveniq 62 Azixa 62 evaluating satraplatin 62 rNAPc2 62 favorable pharmacokinetic 62 mGluR5 negative 62 GLPG# 62 OncoVEX 62 Dacogen injection 62 TLR8 agonist 62 KSP inhibitor 62 sapacitabine 62 valopicitabine NM# 62 TransVax tm 62 rindopepimut 62 Cinryze ™ 62 telaprevir VX 62 inhibitor RG# 62 Kinoid 62 ZFP Therapeutic 62 Collategene 62 Androxal TM 62 JZP 62 tremelimumab 62 rolapitant 62 Relovair 61 AERx ® 61 Enkephalin 61 compound INCB# 61 Ketotransdel TM 61 Xcytrin R 61 SinuNase 61 Phase Ib II 61 bardoxolone 61 Sudhir Agrawal D.Phil 61 ALVESCO HFA 61 AGILECT R 61 Silodosin 61 Neurodex 61 TRX1 61 diagnostic molecular imaging 61 ZYBRESTAT 61 G#DT 61 oral nucleoside analogue 61 demonstrated antitumor activity 61 severe gastroparesis 61 siRNA therapeutics 61 anticancer compound 61 recurrent metastatic ovarian cancer 61 Laquinimod 61 Tezampanel 61 drug GAP #B# 61 Hsp# Inhibitor 61 CRLX# 61 Intraject 61 ONTAK 61 zileuton IV 61 immunological diseases 61 Meets Primary Endpoint 61 NVA# 61 investigational hepatitis C 61 Interferon alpha 61 DepoDur 61 Intravenous CP 61 postoperative ileus POI 61 vaccines oncolytic virus 61 luliconazole 61 tasimelteon 61 EDEMA3 trial 61 bosutinib 61 Zemplar Capsules 61 Viprinex TM 61 Sebivo 61 HQK 61 maximally tolerated dose 61 DexaSite 61 IIa clinical 61 ZK EPO 61 Catena ® 61 CINTREDEKIN BESUDOTOX 61 human IgG1 monoclonal 61 Initiates Clinical 61 drug ISA# 61 punctal plug delivery 61 5 HT2C 61 ZFP Therapeutics 61 refractory gout 61 TKB# 61 TELINTRA R 61 taxane resistant 61 BCX# 61 Prodarsan R 61 vascular disrupting agent 61 Unit Dose Budesonide 61 Soliris TM eculizumab 61 Maribavir 61 PANVAC VF 61 Oracea TM 61 davalintide 61 Orazol 61 Aurora kinase inhibitors 61 Linjeta TM 61 pramlintide metreleptin combination 61 OMP #M# 61 generation URAT1 inhibitor 61 rasagiline tablets 61 DU #b 61 OMS# 61 Perceiva 61 Cethromycin 61 Tarceva TM 61 SomatoKine 61 danoprevir 61 relapsed MM 61 NEUMUNE 61 Phase Ib IIa 61 targeting PCSK9 61 TOLAMBA 61 seliciclib CYC# 61 ancrod 61 XL# XL# XL# 61 Xerecept 61 albiglutide 61 Pivotal Phase 61 Frova ® 61 Iluvien ® 61 ORE# 61 DURIN TM 61 TACI Ig 61 candidate Zenvia 61 inflammatory autoimmune diseases 61 Protexia ® 61 trastuzumab DM1 61 candidates Azedra TM 61 TRAIL receptor antibodies 61 either acutely decompensated 61 tubulin inhibitor 61 GW# [003] 61 Voraxaze 61 proprietary intravenous formulation 61 mTOR inhibition 61 PSN# [001] 61 GERD migraine headaches 61 pharmacological chaperone 61 Cleviprex TM clevidipine 61 SEPET TM 61 bafetinib 61 allosteric modulator NAM 61 HP Acthar Gel repository 61 dimebon latrepirdine 61 Zalbin 61 Aviptadil 61 BRAF inhibitor 61 orally inhaled 61 AVE# 61 Luramist 61 Phase 1b clinical trials 61 Generx TM 61 HCV polymerase 61 dacetuzumab 61 5 fluorouracil leucovorin 61 Amigal 61 Campath alemtuzumab 61 Selective Electrochemical Tumor Ablation 61 Oglemilast 61 Kamada AAT 61 FUSILEV enhances 61 siRNA therapeutic 61 pharmacodynamic properties 61 Ventavis ® 61 2 methoxyestradiol 61 EOquin 61 orBec 61 ChronVac C R 61 DermaVir Patch 61 oral rivaroxaban 61 immunotherapeutic approaches 61 5 HT3 antagonist 61 oral deforolimus 61 IND submission 61 initiate Phase 2b 61 Pazopanib 61 Immunotherapeutic 61 oxypurinol 61 intranasal insulin 61 zileuton CR 61 GVAX cancer 61 Aryplase 61 Poly ICR 61 budesonide MMX Phase III 61 ONCONASE 61 herpetic keratitis 61 ELND-#/AZD-# 61 Ophena 61 Glufosfamide 61 aurora kinase 61 next generation URAT1 61 VEGFR2 inhibitor 61 anti amnesic 61 alefacept 61 anticoagulant reversing agent 61 thorough QT 61 MBP# [001] 61 RELOVAIR ™ 61 gemcitabine Gemzar ® 61 Neulasta ® 61 Xeloda ® 61 LUMINATE 61 Hedgehog agonist 61 intravenous acetaminophen 61 relapsed ALL 61 REOLYSIN ® 61 nalbuphine ER 61 Hyphanox 61 AKT inhibitor 61 Aurora Kinase 61 epothilone 61 rhITF 61 uricase 61 Inhalation Solution 61 Zoraxel TM 61 Phase 2b clinical 61 Pagoclone 61 adenosine injection 61 PEG Interferon lambda 61 sd rxRNA compounds 61 indibulin 61 MEK inhibitor RDEA# 61 Cloretazine R 61 inhaled antibiotic 61 Anturol ® 61 MoxDuo IR 61 OMAPRO ™ 61 JAK1 61 motesanib 61 gastro intestinal inflammation 61 Cimzia TM 61 Vandetanib 61 APTIVUS 61 VIBEX MTX 61 Keppra XR 61 pregabalin Lyrica 61 Elisabeth Lindner CEO 61 ATPace 61 TLK# 61 ATPace TM 61 plus prednisone prednisolone 61 BEMA Granisetron 61 EOquin TM 61 PD LID 61 cyclophilin inhibitor 61 histone deacetylase inhibitor 61 immunomodulating 61 optimal dosing 61 CCX# B 61 Begins Dosing 61 PEGylated Fab fragment 61 OXi# 61 oral proteasome inhibitor 61 pain palliation 61 basal insulin analogue 61 Plenaxis TM 61 Naproxcinod 61 cediranib 61 nonclinical studies 61 ProSavin 61 #D#C# 61 naronapride 61 biomodulator 61 IMiDs ® 61 nicotinic alpha 7 61 mapatumumab 61 selective S#P# receptor agonist 61 polycythemia vera essential thrombocythemia 61 Akt inhibitor 61 dasatinib Sprycel ® 61 unique alkylating agent 61 Dasatinib 61 telomerase inhibitor drug 61 ACTEMRA TM 61 TRV# [001] 61 HspE7 61 ibudilast 61 oral dnaJP1 61 LHRH antagonist 61 MIST II 61 Gleevec resistant 61 Initiate Clinical Trial 61 CD# antibody [001] 61 zileuton 61 orally dosed 61 Auxilium transmucosal film 61 opioid naive 61 vinca alkaloid 61 highly purified pasteurized 61 2 inhibitor CYT# 61 romidepsin novel 61 Fodosine 61 Thiovir 61 IMPDH inhibitor 60 Initiate Phase 60 iSONEP 60 INS# [001] 60 THALOMID 60 balsalazide tablet 60 nucleoside analog 60 OMNARIS AQ 60 Zerenex TM 60 Phase #/#a 60 Tanespimycin 60 SUCCEED trial 60 Viramidine 60 Granulocyte Colony Stimulating Factor 60 ® natalizumab 60 Cintredekin Besudotox 60 safinamide 60 muscarinic receptor agonist 60 candidate deforolimus 60 preclinical efficacy 60 OMP #R# 60 convenient dosing regimens 60 Panzem ® 60 apoptosis inducer 60 oxaliplatin Eloxatin 60 Prestara TM 60 Difimicin 60 SCH # 60 investigational HCV polymerase 60 novel histone deacetylase 60 M# rationally 60 Genasense ® oblimersen 60 acadesine 60 COMT inhibitors 60 brivaracetam 60 hyperphenylalaninemia HPA due 60 markets Gelclair R 60 alemtuzumab MS 60 URG# 60 pharmacodynamic markers 60 initiated Phase 1b 60 Telatinib 60 HDL Mimetic Peptide 60 Phase 2a clinical 60 Kuvan R